RBC plans two-year contingent coupon barrier autocallables on stocks

By Susanna Moon

Chicago, Sept. 15 – Royal Bank of Canada plans to price autocallable contingent coupon barrier notes due Sept. 26, 2019 linked to the lesser performing of the common stocks of Amgen Inc. and Bristol-Myers Squibb Co., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 7.42% to 8.42% if each stock closes at or above its 65% coupon barrier on the observation date for that quarter.

The notes will be called at par if each stock closes its initial level on any coupon payment date after six months.

The payout at maturity will be par unless either stock finishes below its 65% trigger level, in which case investors will be fully exposed to any losses of the worse performing stock.

RBC Capital Markets, LLC is the underwriter.

The notes will price on Sept. 22 and settle on Sept. 27.

The Cusip number is 78012K6P7.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.